FDA Inspection 1178110 — Continental Services Group, Inc.

Continental Services Group, Inc. — FEI 1070217

The FDA completed an inspection of Continental Services Group, Inc. on August 24, 2022 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami, FL (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
924321 CFR 630.40(a)Notification